---
title: "Landfar Bio-medicine expects to turn a profit, with a projected net profit of 12.5 million to 15.5 million yuan for the fiscal year 2024, compared to a loss in the previous year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225680015.md"
description: "Landfar Bio-medicine expects a net profit of 12.5 million to 15.5 million yuan for the fiscal year 2024, turning a profit compared to the previous year. The improvement in performance is mainly attributed to a decrease in financial costs, an increase in the profitability of the cell business, and a rise in revenue from self-operated beauty products and other agency sales"
datetime: "2025-01-21T11:40:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225680015.md)
  - [en](https://longbridge.com/en/news/225680015.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225680015.md)
---

# Landfar Bio-medicine expects to turn a profit, with a projected net profit of 12.5 million to 15.5 million yuan for the fiscal year 2024, compared to a loss in the previous year

According to the Zhitong Finance APP, Landfar Bio-medicine (000504.SZ) released its annual performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company to be between 12.5 million and 15.5 million yuan, turning from a loss to a profit year-on-year.

Reasons for performance changes: 1. During the reporting period, with the improvement of the company's financial situation and capital structure, the company's financial costs decreased significantly compared to the previous year; 2. During the reporting period, through optimizing business management, the overall profitability of the company's cell business improved compared to last year; 3. During the reporting period, the company increased its income and profit sources by further strengthening the sales of self-operated beauty products and expanding the agency sales of other products in related fields

### Related Stocks

- [000504.CN](https://longbridge.com/en/quote/000504.CN.md)
- [300740.CN](https://longbridge.com/en/quote/300740.CN.md)
- [002763.CN](https://longbridge.com/en/quote/002763.CN.md)
- [300957.CN](https://longbridge.com/en/quote/300957.CN.md)
- [300027.CN](https://longbridge.com/en/quote/300027.CN.md)
- [300426.CN](https://longbridge.com/en/quote/300426.CN.md)
- [EL.US](https://longbridge.com/en/quote/EL.US.md)
- [603605.CN](https://longbridge.com/en/quote/603605.CN.md)

## Related News & Research

- ['Am I out?' Drought and rising costs from Iran war deepen pain for US farmers](https://longbridge.com/en/news/287042948.md)
- [NorthPalm Capital Launches as AI-Augmented Investment Company | SCYRF Stock News](https://longbridge.com/en/news/286914222.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)